Medical therapy (n = 54) | Revascularisation (n = 109) | p | |
Age (average ± SD) | 72.2 ± 9.8 | 64.6 ± 10.7 | 0.001 |
Sex, female (%) | 33.3 | 19.3 | 0.048 |
Diabetes (%) | 46.3 | 40.4 | 0.471 |
Dyslipidemia (%) | 61.8 | 62 | 0.909 |
Arterial hypertension (%) | 68.5 | 63.4 | 0.559 |
Smoking | 0.001 | ||
Active | 11.1 | 22.9 | |
Ex-smoker | 24.1 | 43.6 | |
No | 64.8 | 33.9 | |
Obesity (%) | 18.5 | 25.7 | 0.308 |
History of MI (%) | 46.3 | 25.7 | 0.008 |
History of angina (%) | 53.7 | 41.3 | 0.134 |
Family history of HF (%) | 5.7 | 7.3 | 0.690 |
History of stroke (%) | 1.9 | 4.6 | 0.383 |
History of IC (%) | 18.5 | 6.4 | 0.017 |
Peripheral artery disease (%) | 22.2 | 14.7 | 0.229 |
Reduced EF (%) | 31.5 | 22 | 0.190 |
Severity of LMCAD | 0.239 | ||
CT > 90% | 9.3 | 17.4 | |
CT: 71% - 90% | 18.5 | 22.9 | |
CT: 50 - 70 | 72.2 | 59.6 | |
Clinical instability (%) | 74.1 | 71.6 | 0.735 |
Associated vessels | 0.012 | ||
3 vessels | 66.7 | 41.3 | |
2 vessels | 22.2 | 30.3 | |
1 vessel | 9.3 | 17.4 | |
0 vessels | 1.9 | 11 |